[{"from": "human", "value": "Provide a description of this molecule. [C][N][C][C@H1][C][C][Branch1][Branch2][C][C@H1][Ring1][Branch1][C][Ring1][Branch2][C][O][C][=C][Branch2][Ring1][P][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][N][=C][N][=C][Ring1][#Branch1][N][C][=C][Branch1][=N][C][=Branch1][=Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][Cl][Cl][F][O][C]"}, {"from": "gpt", "value": "The molecule is a member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an epidermal growth factor receptor antagonist. It is a member of quinazolines, an aromatic ether, a member of monofluorobenzenes, a dichlorobenzene, a secondary amino compound, a diether and a tertiary amino compound."}]